Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pfitzner

Showing results (401-410 of 427) with videos related to

Pageof 43
Sort By:
Neoplasia (New York, N.Y.)|July 23, 2005
Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growthFlorian M Corvinus, Carina Orth, Richard Moriggl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2016
Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast CancerSibylle Loibl, Silvia Darb-Esfahani, Jens Huober, et al.
The Journal of Pathology. Clinical Research|November 12, 2020
TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanismsMaren Schmiester, Anna Dolnik, Uwe Kornak, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2019
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancerPhilipp Jurmeister, Anne Schöler, Alexander Arnold, et al.
Breast Cancer Research and Treatment|November 28, 2017
Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancerS L Villegas, S Darb-Esfahani, G von Minckwitz, et al.
BMC Cancer|July 30, 2014
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypesSilvia Darb-Esfahani, Gunter von Minckwitz, Carsten Denkert, et al.
Clinical Immunology (Orlando, Fla.)|November 5, 2016
A distinct microbiota composition is associated with protection from food allergy in an oral mouse immunization modelSusanne C Diesner, Cornelia Bergmayr, Barbara Pfitzner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2018
Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular PredictorSibylle Loibl, Karsten Weber, Jens Huober, et al.
Cancers|October 27, 2022
Changes of Protein Expression after CRISPR/Cas9 Knockout of miRNA-142 in Cell Lines Derived from Diffuse Large B-Cell LymphomaJennifer Menegatti, Jacqueline Nakel, Youli K Stepanov, et al.
BMC Genomics|February 12, 2025
Optimal SpCas9- and SaCas9-mediated gene editing by enhancing gRNA transcript levels through scaffold poly-T tract reductionYu C J Chey, Luke Gierus, Caleb Lushington, et al.
Pageof 43

Showing results (401-410 of 427) with videos related to

Sort By:
Pageof 43
Neoplasia (New York, N.Y.)|July 23, 2005
Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growthFlorian M Corvinus, Carina Orth, Richard Moriggl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2016
Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast CancerSibylle Loibl, Silvia Darb-Esfahani, Jens Huober, et al.
The Journal of Pathology. Clinical Research|November 12, 2020
TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanismsMaren Schmiester, Anna Dolnik, Uwe Kornak, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2019
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancerPhilipp Jurmeister, Anne Schöler, Alexander Arnold, et al.
Breast Cancer Research and Treatment|November 28, 2017
Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancerS L Villegas, S Darb-Esfahani, G von Minckwitz, et al.
BMC Cancer|July 30, 2014
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypesSilvia Darb-Esfahani, Gunter von Minckwitz, Carsten Denkert, et al.
Clinical Immunology (Orlando, Fla.)|November 5, 2016
A distinct microbiota composition is associated with protection from food allergy in an oral mouse immunization modelSusanne C Diesner, Cornelia Bergmayr, Barbara Pfitzner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2018
Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular PredictorSibylle Loibl, Karsten Weber, Jens Huober, et al.
Cancers|October 27, 2022
Changes of Protein Expression after CRISPR/Cas9 Knockout of miRNA-142 in Cell Lines Derived from Diffuse Large B-Cell LymphomaJennifer Menegatti, Jacqueline Nakel, Youli K Stepanov, et al.
BMC Genomics|February 12, 2025
Optimal SpCas9- and SaCas9-mediated gene editing by enhancing gRNA transcript levels through scaffold poly-T tract reductionYu C J Chey, Luke Gierus, Caleb Lushington, et al.
Pageof 43